PHIO
Phio Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
5.47 / 10
Netural
Analyst sentiment is dominated by a single Strong Buy, yet historical win rates are low. Fund‑flow score is 7.36/10 with good inflow ratios despite a negative trend, indicating supportive capital but mixed confidence.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-10
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate0.0%
Is money flowing into or out of PHIO?
- PHIO holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.47/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
